Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.4M, listed on NASDAQ, employing roughly 5 people, carrying a beta of 0.00 to the broader market. Lakewood-Amedex Biotherapeutics, Inc. Led by Kelvin Cooper, public since 2026-04-23.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for LABT as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →